{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383388845803544838.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Masaaki Muramatsu"}],"foaf:familyName":[{"@value":"Muramatsu"}],"foaf:givenName":[{"@value":"Masaaki"}]}],"career":[{"institution":{"notation":[{"@value":"Division of Medicinal Safety Science, National Institute of Health Sciences, 1-18-11 Kamiyoga, Setagaya-ku, Tokyo"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363388845803544832","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.2217/14622416.9.11.1617"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.2217/14622416.9.11.1617"},{"@type":"PMID","@value":"19018717"}],"notation":[{"@value":"HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2217/14622416.9.11.1617_Q30IPEKiCJomzfHs0crpvp9b29R"},{"@type":"OPENAIRE","@value":"doi_dedup___::a88150b567b8fad68becb5504b3b8187_Q30IPEKiCJomzfHs0crpvp9b29R"}]}